ARTICLE | Financial News
Chinese companies MabSpace and ICT announce series B rounds
May 10, 2018 9:04 PM UTC
MabSpace Biosciences Co. Ltd. (Suzhou, China) and Innovative Cellular Therapeutics Co. Ltd. (Shanghai, China) raised $40 million and RMB180 million ($28.3 million), respectively, in series B rounds.
New investor Sequoia Capital China led MabSpace’s round with participation from new investor King Star Capital and existing investor Lilly Asia Ventures...